Showing results (11-20 of 13) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Infection|September 14, 2022
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory functionIldiko Madurka, Alexander Vishnevsky, Joan B Soriano, et al.Blood|February 28, 2022
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemiaDavid C Rees, Yurdanur Kilinc, Selma Unal, et al.The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.Pageof 2